BPG BPG GmbH
Back to the news
blau-gelber Hintergrund

Crowe Advises 1Q Health on the Acquisition of Gelpell AG

Advisory

Crowe advised the 1Q Health Group (“1Q Health”), a portfolio company of NORD Holding in the CDMO sector for dietary supplements and pharmaceuticals, on its acquisition of Gelpell AG (“Gelpell”), a Swiss softgel specialist.

Gelpell AG specializes in the development and contract manufacturing of soft gelatin capsules (softgels), hard capsules, and vegetarian capsules. The company offers its customers a comprehensive full-service solution, ranging from product development and regulatory support to a wide variety of packaging solutions and flexible batch sizes.

1Q Health is a leading European dietary supplement and pharmaceutical CDMO and development partner. The group focuses on supporting dynamic clients throughout the entire product lifecycle and beyond—from development and production to logistics and regulatory support. At state-of-the-art production sites in Germany, Austria, the Netherlands, and now also in Switzerland, softgels, hard capsules, liquids, powders, and tablets are manufactured under GMP and IFS/FSSC conditions. In addition, 1Q Health supports customers with their international marketing and online presence.

The acquisition of Gelpell AG is an important strategic step for the 1Q Health Group: It strengthens the Group’s presence in the DACH region and expands its portfolio to include another technologically advanced and attractive dosage form.

The team at Crowe BPG (crowe-bpg.de), which was responsible for the financial due diligence and business advisory services, consisted of Andreas Hoffmann, Certified Public Accountant and Partner (Overall Management), Holger Redle, Associate Manager, and Vanessa Schulz, Consultant.

The tax due diligence, tax structuring advice, and tax contract advice were provided by Dr. Philipp Kruse, Certified Tax Advisor and Partner (overall management) (Crowe BPG); Stefan Wigger, Certified Tax Expert and Partner (Balmer-Etienne AG, CH); and Marco Frappa, Certified Tax Expert (Balmer-Etienne AG, CH).

Source: Deal Advisors by Majunke

Authors

Andreas Hoffmann
Andreas Hoffmann
Philipp Kruse
Dr. Philipp Kruse

Further interesting topics

Advisory

Crowe BPG Advises Cornus Holding on the Acquisition of XARIS GmbH

Crowe BPG advised Cornus Holding GmbH on its acquisition of XARIS GmbH (“XARIS”), based in Vienna. With this acquisition, Cornus Holding continues its compounding strategy focused on the DACH region and enters the market for digital process services related to dealer financing, leasing, and inventory management.
Advisory

Crowe BPG Advises Cornus Holding on the Acquisition of VENTAFLEX GmbH & Co. KG

Crowe BPG advised Cornus Holding GmbH on its acquisition of VENTAFLEX GmbH & Co. KG (“VENTAFLEX”), based in Altenberge (North Rhine-Westphalia). With this acquisition, Cornus Holding is laying the...
Advisory

Revision of IDW S 1: "Principles for the Performance of Business Valuations" – An Overview of the Most Important Changes

IDW S 1 is the authoritative standard for business valuations in Germany and enjoys high recognition, particularly in legal valuation contexts. In jurisprudence, the standard...
Advisory

Crowe BPG advises PINOVA on its investment in KIST + ESCHERICH GmbH

Funds advised by PINOVA Capital GmbH (“PINOVA”) have acquired a stake in KIST + ESCHERICH GmbH (“KIST + ESCHERICH”), which is headquartered in Munich and Dresden.
Advisory

Crowe advises the shareholders of HOMMEL PHARMA on the sale of their shares in VITAIRA

Crowe advised a shareholder of Hommel Pharma GmbH & Co. KG, a pharmaceutical and healthcare services provider (“HOMMEL PHARMA”) based in Dülmen, on the sale of...
Advisory

Crowe advises VALEARA on the acquisition of IVS

Crowe BPG advised VALEARA, a leading provider of psychiatric and neurological care, on the acquisition of IVS.
Advisory

Crowe advises 1Q Health on the acquisition of a majority stake in the EHF Group

Crowe advised the 1Q Health Group (“1Q Health”), a portfolio company of NORD Holding in the CDMO sector for dietary supplements and pharmaceuticals, on its acquisition of the EHF Group (“EHF”), a Dutch developer and manufacturer of dietary supplements.
Advisory

Crowe supports GENUI in the sale of its majority stake in the VALEARA Group to Luxempart

Crowe advised GENUI GmbH (“GENUI”), a private investment company based in Hamburg and Zurich, on the sale of a majority stake in the VALEARA Group to Luxempart S.A., a...
Cookie-Settings